{
    "2018-05-07": [
        [
            {
                "time": "",
                "original_text": "A股正式‘入摩’近在咫尺，外资机构重点布局股曝光",
                "features": {
                    "keywords": [
                        "A股",
                        "入摩",
                        "外资机构",
                        "布局"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "QFII一季度新进增持143股",
                "features": {
                    "keywords": [
                        "QFII",
                        "一季度",
                        "新进增持",
                        "143股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[看好评级]医药生物行业周报：降价控费再下一城 政策落地提速",
                "features": {
                    "keywords": [
                        "医药生物",
                        "降价控费",
                        "政策",
                        "落地提速"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药生物行业研究周报：医药浪潮有望填平低估洼地 消费升级盛夏高潮迭起",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医药浪潮",
                        "消费升级",
                        "低估洼地"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：行业分化、集中度提升明显 紧握高景气龙头",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业分化",
                        "集中度提升",
                        "高景气龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：全行业景气度回升 继续推荐优质成长股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "景气度回升",
                        "优质成长股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "申万宏源：医药生物全行业景气度回升",
                "features": {
                    "keywords": [
                        "申万宏源",
                        "医药生物",
                        "景气度回升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "本周股市三大猜想及策略：股指持续震荡？",
                "features": {
                    "keywords": [
                        "股市",
                        "三大猜想",
                        "策略",
                        "股指震荡"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "社保和公募共同青睐股曝光 医药板块最受宠(名单)",
                "features": {
                    "keywords": [
                        "社保",
                        "公募",
                        "医药板块",
                        "青睐"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "基金‘求同’新高度：171只共‘饮’茅台 重合超五成证金重仓股",
                "features": {
                    "keywords": [
                        "基金",
                        "求同",
                        "茅台",
                        "证金重仓股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}